Business Description
Indegene Ltd
ISIN : INE065X01017
Description
Indegene Ltd provide digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions cover all aspects of commercial, medical, regulatory and R&D operations of life sciences companies. Company segment includes Enterprise Commercial Solutions, Omnichannel Activation, Enterprise Medical Solutions and others. Key revenue is generated from Omnichannel Activation.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.97 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.37 | |||||
| Debt-to-EBITDA | 4.51 | |||||
| Interest Coverage | 7.96 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.75 | |||||
| Quick Ratio | 2.75 | |||||
| Cash Ratio | 1.5 | |||||
| Days Sales Outstanding | 334.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | 12.31 | |||||
| Net Margin % | 7.72 | |||||
| FCF Margin % | 17.62 | |||||
| ROE % | 4.08 | |||||
| ROA % | 2.07 | |||||
| ROIC % | 3.49 | |||||
| ROC (Joel Greenblatt) % | 31.33 | |||||
| ROCE % | 4.96 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 254.67 | |||||
| PE Ratio without NRI | 262.92 | |||||
| PS Ratio | 19.66 | |||||
| PB Ratio | 9.35 | |||||
| Price-to-Tangible-Book | 14.95 | |||||
| Price-to-Free-Cash-Flow | 111.61 | |||||
| Price-to-Operating-Cash-Flow | 95.47 | |||||
| EV-to-EBIT | 133.21 | |||||
| EV-to-EBITDA | 109.07 | |||||
| EV-to-Revenue | 18.76 | |||||
| EV-to-FCF | 109.34 | |||||
| Price-to-Graham-Number | 13.17 | |||||
| Price-to-Net-Current-Asset-Value | 21.24 | |||||
| Earnings Yield (Greenblatt) % | 0.75 | |||||
| FCF Yield % | 0.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Indegene Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 6,322.48 | ||
| EPS (TTM) (₹) | 2.04 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (₹) | 0 | ||
| 20-Day SMA (₹) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (₹) | 508.3 - 660 | ||
| Shares Outstanding (Mil) | 239.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Indegene Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Indegene Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Indegene Ltd Frequently Asked Questions
What is Indegene Ltd(NSE:INDGN)'s stock price today?
The current price of NSE:INDGN is ₹515.80. The 52 week high of NSE:INDGN is ₹660.00 and 52 week low is ₹508.30.
When is next earnings date of Indegene Ltd(NSE:INDGN)?
The next earnings date of Indegene Ltd(NSE:INDGN) is .
Does Indegene Ltd(NSE:INDGN) pay dividends? If so, how much?
Indegene Ltd(NSE:INDGN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers